Kamath J, Yarbrough G G, Prange A J, Winokur A
University of Connecticut Health Center, Department of Psychiatry, 263 Farmington Avenue, Farmington, CT 06030, United States.
Pharmacol Ther. 2009 Jan;121(1):20-8. doi: 10.1016/j.pharmthera.2008.09.004. Epub 2008 Oct 21.
Decades of research have established that the biological functions of thyrotropin-releasing hormone (TRH) extend far beyond its role as a regulator of the hypothalamic-pituitary-thyroid axis. Gary et al. [Gary, K.A., Sevarino, K.A., Yarbrough, G.G., Prange, A.J. Jr., Winokur, A. (2003). The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther 305(2):410-416.] and Yarbrough et al. [Yarbrough, G.G., Kamath, J., Winokur, A., Prange, A.J. Jr. (2007). Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med Hypotheses 69(6):1249-1256.] provided a functional framework, predicated on its global homeostatic influences, to conceptualize the numerous interactions of TRH with the central nervous system (CNS) and endocrine system. Herein, we profer a similar analysis to interactions of TRH with the immune system. Autocrine/paracrine cellular signaling motifs of TRH and TRH receptors are expressed in several tissues and organs of the immune system. Consistent with this functional distribution, in vitro and in vivo evidence suggests a critical role for TRH during the developmental stages of the immune system as well as its numerous interactions with the fully developed immune system. Considerable evidence supports a pivotal role for TRH in the pathophysiology of the inflammatory process with specific relevance to the "cytokine-induced sickness behavior" paradigm. These findings, combined with a number of documented clinical actions of TRH strongly support a potential utility of TRH-based therapeutics in select inflammatory disorders. Similar to its global role in behavioral and energy homeostasis a homeostatic role for TRH in its interactions with the immune system is consonant with the large body of available data. Recent advances in the field of immunology provide a significant opportunity for investigation of the TRH-immune system homeostatic hypothesis. Moreover, this hypothesis may provide a foundation for the development of TRH-based therapeutics for certain medical and psychiatric disorders involving immune dysfunction.
数十年的研究已证实,促甲状腺激素释放激素(TRH)的生物学功能远远超出其作为下丘脑 - 垂体 - 甲状腺轴调节剂的作用。加里等人[加里,K.A.,塞瓦里诺,K.A.,亚尔布鲁,G.G.,普兰奇,A.J. Jr.,维诺克,A.(2003年)。稳态调节的促甲状腺激素释放激素(TRH)假说:对基于TRH的治疗方法的影响。《药理学与实验治疗学杂志》305(2):410 - 416。]和亚尔布鲁等人[亚尔布鲁,G.G.,卡马特,J.,维诺克,A.,普兰奇,A.J. Jr.(2007年)。神经轴中的促甲状腺激素释放激素(TRH):治疗作用反映生理功能和分子作用。《医学假说》69(6):1249 - 1256。]提供了一个基于其全局稳态影响的功能框架,以概念化TRH与中枢神经系统(CNS)和内分泌系统的众多相互作用。在此,我们对TRH与免疫系统的相互作用进行类似的分析。TRH和TRH受体的自分泌/旁分泌细胞信号基序在免疫系统的多个组织和器官中表达。与这种功能分布一致,体外和体内证据表明TRH在免疫系统发育阶段以及它与完全发育的免疫系统的众多相互作用中起关键作用。大量证据支持TRH在炎症过程的病理生理学中起关键作用,特别是与“细胞因子诱导的疾病行为”范式相关。这些发现,再加上TRH的一些已记录的临床作用,有力地支持了基于TRH的治疗方法在某些炎症性疾病中的潜在效用。与其在行为和能量稳态中的全局作用类似,TRH在其与免疫系统相互作用中的稳态作用与大量现有数据一致。免疫学领域的最新进展为研究TRH - 免疫系统稳态假说提供了重要机会。此外,这一假说可能为开发针对某些涉及免疫功能障碍的医学和精神疾病的基于TRH的治疗方法提供基础。